Advanced company searchLink opens in new window

SB DRUG DISCOVERY LIMITED

Company number SC237873

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 Jul 2024 TM01 Termination of appointment of Paul Overton as a director on 20 May 2024
12 Apr 2024 CH01 Director's details changed for Mrs Louisa Elizabeth Jordison on 31 July 2023
12 Jan 2024 CS01 Confirmation statement made on 31 December 2023 with no updates
28 Dec 2023 AA Full accounts made up to 31 March 2023
21 Sep 2023 MR01 Registration of charge SC2378730003, created on 15 September 2023
18 Jan 2023 AA Total exemption full accounts made up to 31 March 2022
16 Jan 2023 CS01 Confirmation statement made on 31 December 2022 with no updates
16 Jan 2023 MA Memorandum and Articles of Association
16 Jan 2023 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
16 Jan 2023 AP01 Appointment of Mr Paul Overton as a director on 16 December 2022
13 Jan 2023 TM01 Termination of appointment of Eric Macdonald Smith as a director on 16 December 2022
13 Jan 2023 TM01 Termination of appointment of David Dalrymple as a director on 16 December 2022
13 Jan 2023 TM01 Termination of appointment of Ian Mcphee as a director on 16 December 2022
13 Jan 2023 AP01 Appointment of Mr Jonathan Williams as a director on 16 December 2022
13 Jan 2023 TM02 Termination of appointment of David Dalrymple as a secretary on 16 December 2022
13 Jan 2023 AP01 Appointment of Mrs Louisa Jordison as a director on 16 December 2022
13 Jan 2023 AP01 Appointment of Mr Simon Hirst as a director on 16 December 2022
16 Dec 2022 MR04 Satisfaction of charge SC2378730002 in full
13 Dec 2022 AR01 Annual return made up to 8 October 2008 with full list of shareholders
13 Dec 2022 AR01 Annual return made up to 8 October 2007 with full list of shareholders
13 Dec 2022 SH01 Statement of capital following an allotment of shares on 1 June 2007
  • GBP 5,380
29 Nov 2022 RP04CS01 Second filing of Confirmation Statement dated 31 December 2020
28 Nov 2022 RP04CS01 Second filing of Confirmation Statement dated 31 December 2018
13 Sep 2022 AP03 Appointment of Dr David Dalrymple as a secretary on 1 January 2022
06 Jan 2022 CS01 Confirmation statement made on 31 December 2021 with no updates